Bladder cancer intrinsic LRFN2 drives anticancer immunotherapy resistance by attenuating CD8<sup>+</sup> T cell infiltration and functional transitionAnze Yu, Junhang Luo|Journal for ImmunoTherapy of Cancer|2023Cited by 22